Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2026-01-01 @ 7:50 PM
Study NCT ID:
NCT01243632
Status:
COMPLETED
Last Update Posted:
2010-11-18
First Post:
2010-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment
Sponsor:
Institute of Oncology Ljubljana
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
86/12/02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Viljem Kovac, MD, Head of the Mesothelioma Team
Old Organization:
Institute of Oncology Ljubljana
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |